Intuitive Surgical, Inc.
NASDAQ:ISRGMedical - Devices
+$3.65 today
- Market cap
- $145.92B
- Beta
- 1.45
- P/E (TTM)
- 48.3
- EPS (TTM)
- $8.39
Volume 2.20M
Average 2.21M
ISRG EBITDA Margin
EBITDA as a percentage of revenue.
Intuitive Surgical, Inc.NASDAQ: ISRG
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to 21.9%
EBITDA Margin was 21.9% in Q3 FY2026, down 18.6 pp from a year earlier. On a trailing-twelve-month basis it was 36.2%, down 2.8 pp year over year. Over 3 fiscal years it widened by 7.9 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 24 analysts of 45.6% for the fiscal year ending Dec 2026, up from 39.6% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 21.9%-19.8 pp QoQ
- Last fiscal yearDec 2025
- 39.6%+2.1 pp YoY
- LTMSep 2026
- 36.2%-2.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -18.6 pp | +3.0 pp | +21.6 pp |
| 1 year | +2.1 pp | +6.0 pp | +3.9 pp |
| 3 years | +7.9 pp | +4.5 pp | -3.4 pp |
| 5 years | +5.9 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 39.6%
- Year-over-year change
- +2.1pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 39.6% | +2.1pp |
| FY2024 | 2024-12-31 | 37.5% | +3.7pp |
| FY2023 | 2023-12-31 | 33.9% | +2.2pp |
| FY2022 | 2022-12-31 | 31.7% | -6.8pp |
| FY2021 | 2021-12-31 | 38.5% | — |
EBITDA Margin vs competitors
How ISRG compares with its peers on the latest reported figures
- ISRG's LTM Sep 2026 EBITDA Margin of 36.2% is the highest of the 5 companies compared; the peer median is 17.0%.
- Its year-over-year change of -2.8 pp is the 3rd highest of 4, against a peer median of -1.3 pp.
- Over three fiscal years its change of +7.9 pp compares with a peer median of +3.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 36.2% | -2.8 pp | +7.9 pp | |
| LTM Jun 2026 | 25.9% | +5.9 pp | +3.4 pp | |
| FY2025 | 21.7% | -1.3 pp | -0.4 pp | |
| LTM Mar 2026 | 12.4% | -6.5 pp | +10.5 pp | |
| LTM Mar 2026 | -13493.3% | — | — | |
| Peer median (excluding ISRG) | 17.0% | -1.3 pp | +3.4 pp | |
Competitors are the stored peer set for ISRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.71B | 6.22B | 7.12B | 8.35B | 10.06B |
| Cost of Revenue | 1.75B | 2.03B | 2.39B | 2.72B | 3.42B |
| Gross Profit | 3.96B | 4.2B | 4.73B | 5.63B | 6.64B |
| Gross Margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Research & Development | 671M | 879M | 998.8M | 1.15B | 1.31B |
| Selling, General & Admin | 1.47B | 1.74B | 1.96B | 2.14B | 2.39B |
| Operating Expenses | 2.14B | 2.62B | 2.96B | 3.29B | 3.7B |
| Depreciation & Amortization | 310.2M | 365.8M | 454.8M | 462M | 677.1M |
| EBITDA | 2.2B | 1.97B | 2.41B | 3.14B | 3.99B |
| EBITDA Margin | 38.5% | 31.7% | 33.9% | 37.5% | 39.6% |
| Operating Income | 1.82B | 1.58B | 1.77B | 2.35B | 2.95B |
| Operating Margin | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Interest Income | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M |
| Income Before Tax | 1.89B | 1.61B | 1.96B | 2.67B | 3.31B |
| Pre-Tax Margin | 33.1% | 25.8% | 27.5% | 32.0% | 32.9% |
| Income Tax Expense | 162.2M | 262.4M | 141.6M | 336.3M | 434.8M |
| Net Income | 1.7B | 1.32B | 1.8B | 2.32B | 2.86B |
| Net Margin | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| EPS (Basic) | 4.79 | 3.72 | 5.12 | 6.54 | 8.00 |
| EPS (Diluted) | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 |
| Weighted Avg Shares | 356.1M | 355.7M | 351.2M | 355.2M | 356.9M |
| Weighted Avg Shares (Diluted) | 365.8M | 362M | 357.4M | 362M | 362.7M |
Intuitive Surgical, Inc.
NASDAQ:ISRG
Intrinsic Alpha fair value
Locked
Current Price
$420.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.